HUTCHMED (China) (HMDCF) Free Cash Flow (2018 - 2021)
HUTCHMED (China)'s (HMDCF) quarterly Free Cash Flow came in at $96.5 million in Q2 2021, up 200.69% year-over-year from $32.1 million in Q2 2020, and up 692.26% quarter-over-quarter from -$16.3 million in Q1 2021.
Analysis
HUTCHMED (China) (HMDCF) Free Cash Flow (2018 - 2021) Analysis & Trends
HUTCHMED (China) (HMDCF) has reported Free Cash Flow for 4 consecutive years, with $96.5 million the latest figure, recorded in Q2 2021.
- On a quarterly basis, Free Cash Flow rose 200.69% year-over-year to $96.5 million in Q2 2021; TTM through Jun 2021 was $112.7 million, a 28.0% increase from a year earlier, with the FY2025 full-year figure at -$50.5 million, down 374.06% from the prior year.
- Free Cash Flow was $96.5 million for Q2 2021 at HUTCHMED (China), up from -$16.3 million in the prior quarter.
- Over five years, Free Cash Flow peaked at $96.5 million in Q2 2021 and troughed at -$16.3 million in Q1 2021.
- A 4-year average of $19.1 million and a median of $12.2 million in 2018 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow soared 2011.86% in 2019 and slumped 5039.09% in 2021, its largest moves.
- Over 4 years, Free Cash Flow stood at $4.1 million in 2018, then surged by 391.35% to $20.3 million in 2019, then soared by 57.86% to $32.1 million in 2020, then jumped by 200.69% to $96.5 million in 2021.
- The last three Free Cash Flow figures came in at $96.5 million (Q2 2021), -$16.3 million (Q1 2021), and $32.1 million (Q2 2020), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.88 Bn | 197.89 Bn | 7.24 Bn | 3.49 Bn |
| 2 | Gilead Sciences | 181.55 Bn | 178.37 Bn | 6.22 Bn | 3.43 Bn |
| 3 | Vertex Pharmaceuticals | 132.31 Bn | 124.45 Bn | 2.84 Bn | 1.01 Bn |
| 4 | Regeneron Pharmaceuticals | 82.51 Bn | 74.52 Bn | 3.93 Bn | 572.80 Mn |
| 5 | Argenx Se | 61.54 Bn | 56.36 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.69 Bn | 49.55 Bn | 52.00 Mn | -563.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.07 Bn | 30.76 Bn | 992.69 Mn | 292.04 Mn |
| 8 | Biogen | 31.41 Bn | 30.12 Bn | 1.96 Bn | 408.00 Mn |
| 9 | Roivant Sciences | 30.10 Bn | 30.10 Bn | 1.16 Mn | -268.64 Mn |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | 96.53 Mn |
| Mar 31, 2021 | -16.30 Mn |
| Jun 30, 2020 | 32.10 Mn |
| Mar 31, 2020 | 330,000.00 |
| Dec 31, 2019 | 20.34 Mn |
| Sep 30, 2019 | 35.25 Mn |
| Jun 30, 2019 | 3.61 Mn |
| Mar 31, 2019 | 30.28 Mn |
| Dec 31, 2018 | 4.14 Mn |
| Sep 30, 2018 | 1.67 Mn |
| Jun 30, 2018 | -11.48 Mn |
| Mar 31, 2018 | 32.16 Mn |